SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063037
Filing Date
2023-11-13
Accepted
2023-11-13 16:32:33
Documents
78
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20230930.htm   iXBRL 10-Q 3738896
2 EX-3.1 stro-ex3_1.htm EX-3.1 53292
3 EX-10.1 stro-ex10_1.htm EX-10.1 94169
4 EX-31.1 stro-ex31_1.htm EX-31.1 16632
5 EX-31.2 stro-ex31_2.htm EX-31.2 16784
6 EX-32.1 stro-ex32_1.htm EX-32.1 8159
7 EX-32.2 stro-ex32_2.htm EX-32.2 8189
  Complete submission text file 0000950170-23-063037.txt   13125161

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20230930_lab.xml EX-101.LAB 604450
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20230930.xsd EX-101.SCH 85120
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20230930_pre.xml EX-101.PRE 477324
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stro-20230930_def.xml EX-101.DEF 337791
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stro-20230930_cal.xml EX-101.CAL 49948
72 EXTRACTED XBRL INSTANCE DOCUMENT stro-20230930_htm.xml XML 2591415
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 231399402
SIC: 2836 Biological Products, (No Diagnostic Substances)